Effectiveness of venous thromboembolism prophylaxis in patients with liver disease

Table 3 Multivariable analysis of risk factors for development of venous thromboembolism in patients with hepatic cirrhosis

	OR	95%CI
Prophylaxis group	0.99	0.48-2.06
BMI (kg/m2)	2.33	0.38-14.13
Baseline albumin (g/dL)	0.23	0.13-0.42
Baseline hemoglobin (g/dL)	1.18	0.99-1.41
Male sex	1.57	0.68-3.61

MELD: Model for end-stage liver disease; BMI: Body mass index.